Treating restless legs syndrome: current pathophysiological concepts and clinical trials

Expert Opinion on Investigational Drugs
Björn Wito Walther

Abstract

Restless legs syndrome is a distinctive clinical syndrome with a prevalence of about 5% in the general population. One of the outstanding characteristics of restless legs syndrome is its extreme responsiveness to dopaminergic agents. Together with the latest pathophysiological and genetic findings, recent epidemiological and clinical data give a new insight into the classification of restless legs syndrome, thus building the theoretical foundation for the development of new pharmacological methods in its treatment. Current efforts within this area focus on establishing dopaminergic substances for therapy. The hypothesis of a disturbed iron metabolism in restless legs syndrome has been revived by recent theoretical considerations. The present review attempts to explain current strategies of treatment for restless legs syndrome in relation to aetiological, genetic and pathophysiological findings.

References

Aug 1, 1986·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·D BoghenJ Montplaisir
Jan 1, 1987·Clinical Neuropharmacology·S Akpinar
Oct 1, 1987·Medical Hypotheses·S S Missak
Mar 27, 1971·British Medical Journal·I Machtey
Jan 1, 1983·European Journal of Clinical Pharmacology·O LundvallR Holm
Jun 1, 1984·Acta Neurologica Scandinavica·P MontagnaE Lugaresi
Feb 11, 1984·British Medical Journal·W TelstadR Nyberg-Hansen
Nov 1, 1982·Archives of Neurology·S Akpinar
Oct 1, 1980·Annals of Neurology·R M ColemanE D Weitzman
Jan 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·D DresslerC D Marsden
Jul 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·B HemmerG Deuschl
Apr 1, 1993·Electroencephalography and Clinical Neurophysiology·C TrenkwalderW Paulus
Jan 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·S IannacconeS Smirne
Oct 1, 1994·Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS·H VahediC J Krenz
May 1, 1994·Age and Ageing·S T O'KeeffeJ N Lavan
Feb 1, 1993·Neurology·C GuilleminaultP Philip
Sep 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·A S Walters
Apr 1, 1996·Sleep·G A Mellick, L B Mellick
Nov 11, 1996·Archives of Internal Medicine·I Machtey, P Tiqwa
Nov 1, 1996·Movement Disorders : Official Journal of the Movement Disorder Society·M S LeeS B Lee
Dec 1, 1996·Neurology·W Ondo, J Jankovic
Jan 1, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·J MontplaisirP Lespérance
Apr 1, 1997·Clinical Neuropharmacology·C H Adler
May 1, 1997·Annals of Neurology·S F BucherC Trenkwalder
Oct 1, 1994·Clinical Neuropharmacology·R GuieuH Rochat
Feb 20, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·V Collado-SeidelC Trenkwalder
Apr 16, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·J MontplaisirG Lavigne
Jan 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·C TrenkwalderS Chokroverty
Jan 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·W Ondo
Jan 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·C TrenkwalderD Eidelberg
Apr 2, 1999·Neurology·J MontplaisirB Gomez-Mancilla
Apr 2, 1999·Neurology·F GemignaniM G Terzano

❮ Previous
Next ❯

Citations

Mar 26, 2003·Anesthesia and Analgesia·Robert Friedman
Oct 3, 2003·Expert Opinion on Pharmacotherapy·Thomas C WetterIlonka Eisensehr

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

EDTNA/ERCA Journal : Official Journal of the European Dialysis and Transplant Nurses Association, European Renal Care Association
T C Wetter
Movement Disorders : Official Journal of the Movement Disorder Society
N Gálvez-Jiménez, T Khan
© 2022 Meta ULC. All rights reserved